Teva Gmbh
SpainAll drugs from this manufacturer
-
It is used to prevent migraine in adults who suffer from at least 4 migraine days per month.
Dosage form: solution for injection
Active substance Dosage fremanezumab 225 mg -
It is used to prevent migraine in adults who suffer from at least four migraine days per month. It helps to reduce the frequency of attacks, the number of headache days, and the associated disability.
Dosage form: solution for injection
Active substance Dosage fremanezumab 225 mg -
It is used for the treatment of relapsing forms of multiple sclerosis (MS) in order to reduce the number of relapses. It may also be used in patients who have experienced first symptoms indicating a high risk of developing the disease.
Dosage form: solution for injection
Active substance Dosage glatiramer acetate 20 mg -
It is used for the treatment of relapsing forms of multiple sclerosis (MS), in order to reduce the number of attacks or relapses.
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage glatiramer acetate 40 mg -
It is used in adults to prevent blood clots after knee or hip replacement, to prevent stroke in people with an irregular heart rhythm (non-valvular atrial fibrillation), and to treat or prevent blood clots in the veins of the legs and lungs. In children, it is used to treat clots and prevent them from reappearing.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate mesylate 126,83 mg -
It is used in adults to prevent the formation of blood clots in the brain (stroke) and other blood vessels in people with non-valvular atrial fibrillation and at least one additional risk factor. It is also used to treat and prevent the recurrence of blood clots in the veins of the legs and lungs. In children, it is used to treat clots and prevent them from reappearing.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate mesylate 172,95 mg -
It is used in adults to prevent the formation of blood clots in the veins following knee or hip replacement surgery. In children, it is used to treat blood clots and prevent them from reappearing.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate mesylate 86,48 mg -
It is used to treat a type of blood cancer called Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in adults and children, either as a new diagnosis or when other treatments have not worked or have caused serious side effects.
Dosage form: capsules, hard
Active substance Dosage nilotinib hydrochloride dihydrate 170,54 mg -
It is used to treat a type of blood cancer called Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in adults and children, either as a new diagnosis or when previous treatments have not worked or have caused serious side effects.
Dosage form: capsules, hard
Active substance Dosage nilotinib hydrochloride dihydrate 227,38 mg -
It is used to treat adults with a type of cancer called multiple myeloma. It may be administered alone with dexamethasone or in combination with bortezomib and dexamethasone.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 3 mg -
It is used to treat adults with a type of cancer called multiple myeloma. It may be administered together with other medicines such as bortezomib and dexamethasone, or alone with dexamethasone, depending on the case.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 4 mg -
It is used to treat postmenopausal osteoporosis in women and bone loss in men at risk of fracture. It is also prescribed for bone loss caused by reduced testosterone in patients with prostate cancer or by long-term treatment with glucocorticoids.
Dosage form: solution for injection
Active substance Dosage denosumab 60 mg/ml -
It is used in adults to prevent the formation of blood clots in the veins following hip or knee replacement surgery. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the blood vessels of the lungs (pulmonary embolism), helping to prevent them from recurring.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 10 mg -
It is used in adults to prevent the formation of blood clots in the brain or other blood vessels in people with an irregular heartbeat called non-valvular atrial fibrillation. It is also used to treat blood clots in the leg veins (deep vein thrombosis) and in the lungs (pulmonary embolism), and to prevent them from reappearing. In children and adolescents weighing more than 30 kg, it is used to treat and prevent the recurrence of these clots following initial treatment with injectable medications.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 15 mg -
It is used in adults to prevent the formation of blood clots in the brain or other blood vessels in people with an irregular heart rhythm called non-valvular atrial fibrillation. It is also used to treat blood clots in the leg veins (deep vein thrombosis) and in the lungs (pulmonary embolism), and to prevent their recurrence. In children and adolescents weighing 30 kg or more, it is used to treat and prevent the recurrence of these clots after initial treatment with injectable medications.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 20 mg